0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(15):1504. doi:10.1001/jama.2014.12463.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(13):1280-1281. doi:10.1001/jama.2013.279755.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(12):1185. doi:10.1001/jama.2014.12756.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10967.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10968.

JAMA Revisited | 
JAMA. 2014;312(8):850. doi:10.1001/jama.2013.279692.

Global Health | 
M. J. Friedrich
JAMA. 2014;312(7):687. doi:10.1001/jama.2014.9498.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9118.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(3):223. doi:10.1001/jama.2014.8181.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(2):117-118. doi:10.1001/jama.2014.7731.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Editorial  | 
Human Neurons Derived From Induced Pluripotent Stem Cells as a New Platform for Preclinical Drug Screening and Development
Fan Liao, PhD; David M. Holtzman, MD
JAMA Ophthalmology
Invited Commentary  | 
We Need to Be Better Prepared for Hydroxychloroquine Retinopathy
Hendrik P. N. Scholl, MD, MA; Syed Mahmood Ali Shah, MBBS
JAMA Ophthalmology
Original Investigation  | 
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles, MD; Michael F. Marmor, MD
JAMA Internal Medicine
Invited Commentary  | 
Legalization of Medical Marijuana and Incidence of Opioid Mortality
Marie J. Hayes, PhD; Mark S. Brown, MD